Crohn’s & Colitis Foundation Awards Funding to Vedanta for New Microbiome-Derived Therapeutic Program

Crohn’s & Colitis Foundation Awards Funding to Vedanta for New Microbiome-Derived Therapeutic Program
The Crohn’s & Colitis Foundation has granted Vedanta Biosciences funding for its new microbiome-derived therapeutic program for the treatment of inflammatory bowel disease (IBD). This program aims to develop therapeutics by using information regarding the gut’s bacterial and microorganism population — collectively referred to as the microbiome — in IBD patients. “As the first commercial

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *